{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:55:56Z","timestamp":1776232556564,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.nbd.2009.12.024","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T04:09:01Z","timestamp":1262664541000},"page":"36-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Galectin-3 contributes to neonatal hypoxic\u2013ischemic brain injury"],"prefix":"10.1016","volume":"38","author":[{"given":"Christina","family":"Doverhag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maj","family":"Hedtj\u00e4rn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Mallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"S\u00e4vman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2009.12.024_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1023\/B:GLYC.0000014088.21242.e0","article-title":"Galectins as inflammatory mediators","volume":"19","author":"Almkvist","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.nbd.2009.12.024_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.10242","article-title":"Minocycline markedly protects the neonatal brain against hypoxic\u2013ischemic injury","volume":"52","author":"Arvin","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.12.024_bib3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00004647-200012000-00007","article-title":"Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94","volume":"20","author":"Asahi","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2009.12.024_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ab.2009.07.012","article-title":"Evaluation of recombinant caspase specificity by competitive substrates","volume":"394","author":"Benkova","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2009.12.024_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.freeradbiomed.2005.08.040","article-title":"Free radicals, mitochondria, and hypoxia\u2013ischemia in the developing brain","volume":"40","author":"Blomgren","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2009.12.024_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1203\/00006450-199904010-00008","article-title":"Chemokine and inflammatory cell response to hypoxia\u2013ischemia in immature rats","volume":"45","author":"Bona","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1460-9568.2005.03982.x","article-title":"IGF-I neuroprotection in the immature brain after hypoxia\u2013ischemia, involvement of Akt and GSK3beta?","volume":"21","author":"Brywe","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.024_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L","article-title":"Embryonic implantation in galectin 1\/galectin 3 double mutant mice","volume":"211","author":"Colnot","year":"1998","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.nbd.2009.12.024_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2567.1998.00517.x","article-title":"Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice","volume":"94","author":"Colnot","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.nbd.2009.12.024_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2008.04.003","article-title":"Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice","volume":"31","author":"Doverhag","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.12.024_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/glycob\/cwi026","article-title":"Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways","volume":"15","author":"Fernandez","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.nbd.2009.12.024_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nri2394","article-title":"The X-files in immunity: sex-based differences predispose immune responses","volume":"8","author":"Fish","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2009.12.024_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drup.2007.04.001","article-title":"The role of galectin-3 in cancer drug resistance","volume":"10","author":"Fukumori","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.nbd.2009.12.024_bib14","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1158\/0008-5472.CAN-05-3750","article-title":"Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer","volume":"66","author":"Fukumori","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib15","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1158\/0008-5472.CAN-04-0336","article-title":"Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways","volume":"64","author":"Fukumori","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1203\/00006450-199610000-00015","article-title":"Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia\u2013ischemia in neonatal rats","volume":"40","author":"Hagberg","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1471-4159.2004.02547.x","article-title":"PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury","volume":"90","author":"Hagberg","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.12.024_bib18","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1523\/JNEUROSCI.22-14-05910.2002","article-title":"Interleukin-18 involvement in hypoxic\u2013ischemic brain injury","volume":"22","author":"Hedtjarn","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.024_bib19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/00004647-200412000-00003","article-title":"Inflammatory gene profiling in the developing mouse brain after hypoxia\u2013ischemia","volume":"24","author":"Hedtjarn","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nbd.2009.12.024_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2004.09.062","article-title":"White matter injury in the immature brain: role of interleukin-18","volume":"373","author":"Hedtjarn","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2009.12.024_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0002-9440(10)64975-9","article-title":"Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses","volume":"156","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2009.12.024_bib22","article-title":"Neuroprotective effect of exogenous microglia in global brain ischemia","author":"Imai","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2009.12.024_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0165-2478(94)90072-8","article-title":"An endogenous lectin, galectin-3 (epsilon BP\/Mac-2), potentiates IL-1 production by human monocytes","volume":"42","author":"Jeng","year":"1994","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.nbd.2009.12.024_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","article-title":"Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Jiang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.024_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S0012162207000199.x","article-title":"Sex and the pathogenesis of cerebral palsy","volume":"49","author":"Johnston","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2009.12.024_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/glycob\/cwn104","article-title":"Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils","volume":"19","author":"Karlsson","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.nbd.2009.12.024_bib27","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.V91.9.3430","article-title":"Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils","volume":"91","author":"Karlsson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.nbd.2009.12.024_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jphs.94.203","article-title":"Intracerebroventricular injection of microglia protects against focal brain ischemia","volume":"94","author":"Kitamura","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2009.12.024_bib29","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1523\/JNEUROSCI.5360-06.2007","article-title":"Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain","volume":"27","author":"Lalancette-Hebert","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.024_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-5-34","article-title":"Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia\u2013ischemia in the neonatal rat","volume":"5","author":"Leonardo","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2009.12.024_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000084545","article-title":"Regulatory roles of galectins in the immune response","volume":"136","author":"Liu","year":"2005","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.nbd.2009.12.024_bib32","first-page":"1016","article-title":"Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages","volume":"147","author":"Liu","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2009.12.024_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0304-4165(02)00313-6","article-title":"Intracellular functions of galectins","volume":"1572","author":"Liu","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2009.12.024_bib34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/00004647-199910000-00006","article-title":"Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic\u2013ischemic brain damage","volume":"19","author":"Liu","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2009.12.024_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1994.1215","article-title":"The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia\u2013ischemia","volume":"130","author":"Martin","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.12.024_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-3806(94)00177-2","article-title":"Microglia activation after neonatal hypoxic\u2013ischemia","volume":"84","author":"McRae","year":"1995","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.cdd.4402260","article-title":"Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways","volume":"15","author":"McStay","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2009.12.024_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.jcbfm.9600342","article-title":"Gender-specific neuroprotection by 2-iminobiotin after hypoxia\u2013ischemia in the neonatal rat via a nitric oxide independent pathway","volume":"27","author":"Nijboer","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2009.12.024_bib39","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1021\/bi00251a020","article-title":"Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9","volume":"33","author":"Ochieng","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2009.12.024_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2008.10.101","article-title":"Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity","volume":"377","author":"Pereira","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2009.12.024_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)01499-3","article-title":"Nerve growth factor-mediated expression of galectin-3 in mouse dorsal root ganglion neurons","volume":"293","author":"Pesheva","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2009.12.024_bib42","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.2006.04269.x","article-title":"Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender","volume":"100","author":"Renolleau","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.12.024_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.410090206","article-title":"The influence of immaturity on hypoxic\u2013ischemic brain damage in the rat","volume":"9","author":"Rice","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.12.024_bib44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/abbi.1998.0658","article-title":"Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway","volume":"353","author":"Sankarapandi","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.nbd.2009.12.024_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200317592","article-title":"Critical role of galectin-3 in phagocytosis by macrophages","volume":"112","author":"Sano","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2009.12.024_bib46","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.165.4.2156","article-title":"Human galectin-3 is a novel chemoattractant for monocytes and macrophages","volume":"165","author":"Sano","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.024_bib47","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1203\/00006450-199806000-00006","article-title":"Cytokine response in cerebrospinal fluid after birth asphyxia","volume":"43","author":"Savman","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib48","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1523\/JNEUROSCI.4391-06.2007","article-title":"Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia\u2013ischemia","volume":"27","author":"Svedin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.024_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2004.01.011","article-title":"Minocycline worsens hypoxic\u2013ischemic brain injury in a neonatal mouse model","volume":"189","author":"Tsuji","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.12.024_bib50","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/01.STR.28.11.2252","article-title":"Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase","volume":"28","author":"Walder","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.nbd.2009.12.024_bib51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/1097-4547(20000815)61:4<430::AID-JNR9>3.0.CO;2-3","article-title":"Galectin-3 is upregulated in microglial cells in response to ischemic brain lesions, but not to facial nerve axotomy","volume":"61","author":"Walther","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000047087","article-title":"Caspase-3 activation after neonatal rat cerebral hypoxia\u2013ischemia","volume":"79","author":"Wang","year":"2001","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.nbd.2009.12.024_bib53","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nbd.2005.12.017","article-title":"Caspase-3 deficiency during development increases vulnerability to hypoxic\u2013ischemic injury through caspase-3-independent pathways","volume":"22","author":"West","year":"2006","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.nbd.2009.12.024_bib54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(80)90024-X","article-title":"An absolute method for protein determination based on difference in absorbance at 235 and 280\u00a0nm","volume":"109","author":"Whitaker","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2009.12.024_bib55","series-title":"Neurology of the Newborn","first-page":"400","article-title":"Hypoxic\u2013ischemic encephalopathy: clinical aspects","author":"Volpe","year":"2008"},{"key":"10.1016\/j.nbd.2009.12.024_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.06.073","article-title":"Galectin-3 mediates post-ischemic tissue remodeling","volume":"1288","author":"Yan","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2009.12.024_bib57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s000180300022","article-title":"Galectins in cell growth and apoptosis","volume":"60","author":"Yang","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2009.12.024_bib58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1471-4159.2003.01832.x","article-title":"Involvement of apoptosis-inducing factor in neuronal death after hypoxia\u2013ischemia in the neonatal rat brain","volume":"86","author":"Zhu","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.12.024_bib59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.cdd.4402053","article-title":"Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia\u2013ischemia","volume":"14","author":"Zhu","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2009.12.024_bib60","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1471-4159.2005.03639.x","article-title":"Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia\u2013ischaemia","volume":"96","author":"Zhu","year":"2006","journal-title":"J. Neurochem."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109003799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109003799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:05:10Z","timestamp":1760850310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109003799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0969996109003799"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.12.024","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galectin-3 contributes to neonatal hypoxic\u2013ischemic brain injury","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}